- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07941193
Effectiveness of a Standardized Healthcare Education Program in People With Heart Failure
Heart failure is a chronic illness with a high prevalence and impact on the quality of life of the people who experience it, associated with high hospital taxes and mortality. Beyond the results of traditional clinics, factors such as health literacy, therapeutic adherence and self-healing play a key role in the evolution of this pathology. Various studies show that inadequate health literacy levels lead to better control of malaria, more re-entry and a lower quality of life.
The objective of this research is to evaluate the effectiveness of a standard health education care program, led by nurses specialized in heart failure, initiating discharge from hospitals and with structured follow-up during the first few months afterward, compared to conventional care. It is intended to analyze its impact on health literacy, therapeutic adherence, self-healing, and quality of life, as well as explore the associated social determinants.
It will last a random clinical trial between two groups (intervention and control) at the Heart Failure Unit of the Figueres Hospital. The participants will be adults admitted for decompensation of heart failure and will be followed for 12 months, with evaluations at admission, at 6 months and at any time after discharge. It is important to serve validated instruments to measure quality of life, health literacy and therapeutic adherence.
It is hoped that the intervention will improve the quality of life and health literacy of people with heart failure, contributing to more equitable care, centered on the person and oriented towards better health outcomes.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Clara Vargas Farber, RN Nurse
- Phone Number: +34972592005
- Email: cvargas@salutemporda.cat
Study Contact Backup
- Name: Silvia Zuheros Santó, Administrative
- Email: szuheros@salutemporda.cat
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- People who are admitted for decompensated heart failure, and who are going to undergo post-discharge monitoring at the Heart Failure Unit of the Figueres Hospital.
- have signed the informed consent.
Exclusion Criteria:
- People diagnosed with cognitive impairment or dementia.
- Institutionalized people.
- Foreign people or people who live outside the hospital's reference area.
- People with language difficulties.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Educational group
In the case of the intervention group, a standardized, structured and more intense follow-up plan than usual will be applied. |
This next step will begin after discharge from the hospital with a face-to-face visit from specialized nursing, in which a comprehensive assessment will be carried out, the administration of measurement scales, individualized health education and coordination of primary care and other assistance devices if necessary. |
|
No Intervention: control group
usual nursing care |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with nursing intervention who need hospital admission in a year
Time Frame: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see how many times they have been admitted for heart failure decompensation. The number of admissions, the main admission diagnosis, and the number of days in the hospital will be reviewed |
From enrollment to the end of treatment at 12 months
|
|
Number of visits to the emergency room in the past year for patients who have undergone the nursing intervention
Time Frame: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see the number of emergency visits for heart failure decompensation. The number of visits to the emergency room, the reason for the visit, the main diagnosis at discharge, and the patient's destination will be checked |
From enrollment to the end of treatment at 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of people with a good level of self-care according to the scale Self-Care of Heart Failure Index who have received intervention from the nurse
Time Frame: From enrollment to the end of treatment at 12 months
|
The questionnaire consists of 22 items spread across three independent scales that assess the patient's behaviors over the past month. The items are answered using a four-point Likert scale. The scores for each scale are calculated separately and converted into standardized values from 0 to 100, where higher scores indicate a better level of self-care. A score of 70 or above is considered indicative of adequate self-care. |
From enrollment to the end of treatment at 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Maria Rosa Suñer Soler, RN, PhD, Universitat de Girona
- Study Chair: Aurora Fontova Almató, RN, PhD, Fundacio Salut Emporda
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026.145
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
It is a single-center study that does not intend to share information with third parties and will only publish the research results.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.